PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Stefan, N. ; Targher, G.*

Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine.

Nat. Rev. Gastroenterol. Hepatol. 22, 226–227 (2025)
Publ. Version/Full Text DOI PMC
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a heterogeneous disease regarding its pathophysiology and clinical outcomes. Two novel studies suggest that different clusters of people with MASLD exist, explaining part of this heterogeneity. These findings and future research applying data dimensionality reduction approaches might be beneficial for implementing precision medicine in MASLD.
Altmetric
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Other: News Item
Language english
Publication Year 2025
HGF-reported in Year 2025
ISSN (print) / ISBN 1759-5045
e-ISSN 1759-5053
Journal Nature Reviews - Gastroenterology & Hepatology
Quellenangaben Volume: 22, Issue: , Pages: 226–227 Article Number: , Supplement: ,
Publisher Nature Publishing Group
Publishing Place Heidelberger Platz 3, Berlin, 14197, Germany
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes Research and Metabolic Diseases (IDM)
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502400-001
Grants European Innovative Medicines Initiative SOPHIA
German Center of Diabetes Research (DZD)
German Federal Ministry of Education and Research (BMBF)
DOI 10.1038/s41575-025-01048-w
WOS ID 001433269600001
Scopus ID 86000017484
PubMed ID 40011752
Erfassungsdatum 2025-04-30
[➜Report correction]